BridgeMD
New treatment option for Locally Advanced Malignant Solid Neoplasm
Official title Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
ClinicalTrials.gov ID: NCT04515810
What this study is testing
- What it's testing
- This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic solid cancer and/or disease progression following at...
- PATIENT: Have internet access through a computer or a mobile device; the principal investigator (PI) will ensure that those who have access to a...
- PATIENT: The ability to provide informed consent.
- PATIENT: Identification of a loved support person if one is available; patients who are unable to identify a support person willing to participate...
- PATIENT: 18 years of age or older.
You likely can't join if
- PATIENT: Not fluent in English.
- PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study...
- PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
- PATIENT: Currently receiving hospice at the time of enrollment.
- PATIENT: Children and young adults under age 18.
See the full eligibility criteria
- PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic solid cancer and/or disease progression following at least first line systemic therapy and/or relapsed or refractory...
- PATIENT: Have internet access through a computer or a mobile device; the principal investigator (PI) will ensure that those who have access to a computer or mobile device have access to a computer or mobile device with...
- PATIENT: The ability to provide informed consent.
- PATIENT: Identification of a loved support person if one is available; patients who are unable to identify a support person willing to participate with them will be allowed to continue in the study on their own.
- PATIENT: 18 years of age or older.
- SUPPORT PERSON: The person (family member or friend) whom the patient indicates being a support person.
- SUPPORT PERSON: English speaking.
- SUPPORT PERSON: 18 years of age or older and able to provide informed consent.
- PROVIDER: Current clinical practice and/or research with advanced cancer patients.
- PROVIDER: A history of 3+ years working with advanced cancer patients.
- PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled.
- PATIENT: Not fluent in English.
- PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study research staff during screening.
- PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
- PATIENT: Currently receiving hospice at the time of enrollment.
- PATIENT: Children and young adults under age 18.
The study team makes the final eligibility decision.
Where it's taking place
- Manhasset, New York, United States
- New York, New York, United States
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Manhasset, New York, United States; New York, New York, United States; Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.